137 related articles for article (PubMed ID: 7664781)
1. Interleukin-2 promoter activity in Epstein-Barr virus-transformed B lymphocytes is controlled by nuclear factor-chi B.
Mouzaki A; Serfling E; Zubler RH
Eur J Immunol; 1995 Aug; 25(8):2177-82. PubMed ID: 7664781
[TBL] [Abstract][Full Text] [Related]
2. Regulation of interleukin-1beta transcription by Epstein-Barr virus involves a number of latent proteins via their interaction with RBP.
Krauer KG; Belzer DK; Liaskou D; Buck M; Cross S; Honjo T; Sculley T
Virology; 1998 Dec; 252(2):418-30. PubMed ID: 9878621
[TBL] [Abstract][Full Text] [Related]
3. An NF-kappa B-like element plays an essential role in interleukin-1-mediated costimulation of the mouse interleukin-2 promoter.
Stricker K; Serfling E; Krammer PH; Falk W
Eur J Immunol; 1993 Jul; 23(7):1475-80. PubMed ID: 8325323
[TBL] [Abstract][Full Text] [Related]
4. Regulation of cytokine gene expression in T helper cell subsets.
Lederer JA; Liou JS; Todd MD; Glimcher LH; Lichtman AH
J Immunol; 1994 Jan; 152(1):77-86. PubMed ID: 8254209
[TBL] [Abstract][Full Text] [Related]
5. Multiple signals are required for function of the human granulocyte-macrophage colony-stimulating factor gene promoter in T cells.
Jenkins F; Cockerill PN; Bohmann D; Shannon MF
J Immunol; 1995 Aug; 155(3):1240-51. PubMed ID: 7636192
[TBL] [Abstract][Full Text] [Related]
6. Cyclic AMP inhibits expression of the IL-2 gene through the nuclear factor of activated T cells (NF-AT) site, and transfection of NF-AT cDNAs abrogates the sensitivity of EL-4 cells to cyclic AMP.
Tsuruta L; Lee HJ; Masuda ES; Koyano-Nakagawa N; Arai N; Arai K; Yokota T
J Immunol; 1995 May; 154(10):5255-64. PubMed ID: 7730629
[TBL] [Abstract][Full Text] [Related]
7. Cooperation of binding sites for STAT6 and NF kappa B/rel in the IL-4-induced up-regulation of the human IgE germline promoter.
Messner B; Stütz AM; Albrecht B; Peiritsch S; Woisetschläger M
J Immunol; 1997 Oct; 159(7):3330-7. PubMed ID: 9317131
[TBL] [Abstract][Full Text] [Related]
8. Nuclear factor-kappa B potently up-regulates the promoter activity of RANTES, a chemokine that blocks HIV infection.
Moriuchi H; Moriuchi M; Fauci AS
J Immunol; 1997 Apr; 158(7):3483-91. PubMed ID: 9120310
[TBL] [Abstract][Full Text] [Related]
9. Octamer factors exert a dual effect on the IL-2 and IL-4 promoters.
Pfeuffer I; Klein-Hessling S; Heinfling A; Chuvpilo S; Escher C; Brabletz T; Hentsch B; Schwarzenbach H; Matthias P; Serfling E
J Immunol; 1994 Dec; 153(12):5572-85. PubMed ID: 7989759
[TBL] [Abstract][Full Text] [Related]
10. Dominant negative mutant of c-Jun inhibits NF-AT transcriptional activity and prevents IL-2 gene transcription.
Petrak D; Memon SA; Birrer MJ; Ashwell JD; Zacharchuk CM
J Immunol; 1994 Sep; 153(5):2046-51. PubMed ID: 8051409
[TBL] [Abstract][Full Text] [Related]
11. Abnormal regulation of the IL-2 promoter in lpr CD4-CD8- T lymphocytes results in constitutive expression of a novel nuclear factor of activated T cells-binding factor.
Clements JL; Cooper SM; Budd RC
J Immunol; 1995 Jun; 154(12):6372-81. PubMed ID: 7759875
[TBL] [Abstract][Full Text] [Related]
12. Differential induction of T cell cytokine mRNA in Epstein-Barr virus-transformed B cell clones: constitutive and inducible expression of interleukin-4 mRNA.
Tang H; Matthes T; Carballido-Perrig N; Zubler RH; Kindler V
Eur J Immunol; 1993 Apr; 23(4):899-903. PubMed ID: 8384561
[TBL] [Abstract][Full Text] [Related]
13. Cytokine induction of monocyte chemoattractant protein-1 gene expression in human endothelial cells depends on the cooperative action of NF-kappa B and AP-1.
Martin T; Cardarelli PM; Parry GC; Felts KA; Cobb RR
Eur J Immunol; 1997 May; 27(5):1091-7. PubMed ID: 9174597
[TBL] [Abstract][Full Text] [Related]
14. [Regulation of transcription of the interleukin-2 gene in B-lymphocytes].
Mouzaki A; Zubler RH
Schweiz Med Wochenschr; 1995 Mar; 125(9):396-9. PubMed ID: 7892566
[TBL] [Abstract][Full Text] [Related]
15. Synergistic transcriptional activation of the IL-8 gene by NF-kappa B p65 (RelA) and NF-IL-6.
Kunsch C; Lang RK; Rosen CA; Shannon MF
J Immunol; 1994 Jul; 153(1):153-64. PubMed ID: 8207232
[TBL] [Abstract][Full Text] [Related]
16. Characterisation of regulatory sequences at the Epstein-Barr virus BamHI W promoter.
Bell A; Skinner J; Kirby H; Rickinson A
Virology; 1998 Dec; 252(1):149-61. PubMed ID: 9875325
[TBL] [Abstract][Full Text] [Related]
17. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
Zerbini LF; Wang Y; Cho JY; Libermann TA
Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
[TBL] [Abstract][Full Text] [Related]
18. Negative regulation of MDR1 promoter activity in MCF-7, but not in multidrug resistant MCF-7/Adr, cells by cross-coupled NF-kappa B/p65 and c-Fos transcription factors and their interaction with the CAAT region.
Ogretmen B; Safa AR
Biochemistry; 1999 Feb; 38(7):2189-99. PubMed ID: 10026303
[TBL] [Abstract][Full Text] [Related]
19. Promoter of the human NF-kappa B p50/p105 gene. Regulation by NF-kappa B subunits and by c-REL.
Cogswell PC; Scheinman RI; Baldwin AS
J Immunol; 1993 Apr; 150(7):2794-804. PubMed ID: 8454856
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin E2 inhibits the nuclear transcription of the human interleukin 2, but not the Il-4, gene in human T cells by targeting transcription factors AP-1 and NF-AT.
Paliogianni F; Boumpas DT
Cell Immunol; 1996 Jul; 171(1):95-101. PubMed ID: 8660843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
